The Effects of a Commercially Available Weight Loss Program among Obese Patients with Type 2 Diabetes: A Randomized Study
The Effects of a Commercially Available Weight Loss Program among Obese Patients with Type 2 Diabetes: A Randomized Study is a paper indexed in PICO Portal from OpenAlex.
How many citations does The Effects of a Commercially Available Weight Loss Program among Obese Patients with Type 2 Diabetes: A Randomized Study have?
The Effects of a Commercially Available Weight Loss Program among Obese Patients with Type 2 Diabetes: A Randomized Study has 49 citations in the OpenAlex counts PICO Portal stores.
When was The Effects of a Commercially Available Weight Loss Program among Obese Patients with Type 2 Diabetes: A Randomized Study published?
The Effects of a Commercially Available Weight Loss Program among Obese Patients with Type 2 Diabetes: A Randomized Study has 2009 year in the PICO Portal index.
What is the open-access status of The Effects of a Commercially Available Weight Loss Program among Obese Patients with Type 2 Diabetes: A Randomized Study?
The Effects of a Commercially Available Weight Loss Program among Obese Patients with Type 2 Diabetes: A Randomized Study has closed oa status in the PICO Portal index.
What is the DOI of The Effects of a Commercially Available Weight Loss Program among Obese Patients with Type 2 Diabetes: A Randomized Study?
The DOI for The Effects of a Commercially Available Weight Loss Program among Obese Patients with Type 2 Diabetes: A Randomized Study is on the source record.
What is the PMID of The Effects of a Commercially Available Weight Loss Program among Obese Patients with Type 2 Diabetes: A Randomized Study?
The PMID for The Effects of a Commercially Available Weight Loss Program among Obese Patients with Type 2 Diabetes: A Randomized Study is on the source record.
What is the OpenAlex record for The Effects of a Commercially Available Weight Loss Program among Obese Patients with Type 2 Diabetes: A Randomized Study?
The OpenAlex for The Effects of a Commercially Available Weight Loss Program among Obese Patients with Type 2 Diabetes: A Randomized Study is on the source record.